MedPath

Safety and efficacy of skin care formulation

Not yet recruiting
Conditions
Volunteers with uneven skin tone and dull skin.
Registration Number
CTRI/2021/08/035607
Lead Sponsor
Kama Ayurveda Pvt Ltd
Brief Summary

Objective: To evaluate the in vivo efficacy and safetyof a skin care formulation in terms of skin even tone, reduction inpigmentation (dark spots), radiant skin, skin brightening, skin moisturization,minimize fine lines and wrinkles, smooth skin and helps in reduction of darkcircles on healthy male and female volunteers

Duration of study: 28 days study

Kinetics: T0, T+14 days and T+28 days

Population: Group 1 36 volunteers

Group 2: 36 volunteers

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria

Having dull skin and uneven skin tone Having pigmentary spot on the face Having Crows feet wrinkle of grade 2 Having visible under eye dark circle.

Exclusion Criteria
  • Having started, changed or interrupted one hormonal treatment (hormonal contraception, Hormone Replacement Therapy) during the past 3 months Having started, changed or stopped her tobacco consumption (for smokers consuming more than 10 cigarettes per day) in the previous 6 months Having consumed caffeine-based products (coffee, cola, tea, …), alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements Having taken a medicinal treatment which could lead to hyper pigmentation (phenytoïn, amiodarone, metals, minocycline…) in the previous 6 months • Taking oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta-carotene…) Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask …) or having applied self-tanning products in the week preceding the start of the study Having applied products with anti-wrinkle action (Retinoic acid, retinol, retinaldehyde, isotretinoin, A.H.A...) in the 2 weeks preceding the start of the study Having applied products with a depigmenting/ whitening action (hydroquinone or derivates…) in the 4 weeks preceding the start of the study.
  • Having undergone physical and/or chemical treatments of the spots (liquid nitrogen, dry ice, pulsed flash lamp, dermabrasion, chemical peel …) in the previous 6 months Having a suntanned skin on the studied areas which could interfere with the evaluations of the study For males, having not shaved their beard 24 hours prior to the day of measurement.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of the product in terms of skin even tone, reduction in pigmentation (dark spots), radiant skin, skin brightening, skin moisturization, minimize fine lines and wrinkles, smooth skin and helps in reduction of dark circlesT0, T14 days and T28 days
Secondary Outcome Measures
NameTimeMethod
SafetyT0, T14 days and T28 days

Trial Locations

Locations (1)

Mascot Spincontrol India Pvt. Ltd.

🇮🇳

(Suburban), MAHARASHTRA, India

Mascot Spincontrol India Pvt. Ltd.
🇮🇳(Suburban), MAHARASHTRA, India
Dr Raji Patil
Principal investigator
022-43349191
raji@mascotspincontrol.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.